SCHEMBL4066623

SCHEMBL4066623

CN(C[CH]Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 2/20 0.50
CARM1 Q86X55 1/20 0.50
PRMT6 Q96LA8 1/20 0.50
PRMT8 Q9NR22 1/20 0.50
LMNA P02545 2/20 0.48
USP2 O75604 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
PYCR1 P32322 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
BLM P54132 1/20 0.47
AOC3 Q16853 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MGLL Q99685 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4069054 0.84 CHRNB2 (0.57) ALDH1A1LMNACYP3A4SMN1; SMN2KDM4E
SCHEMBL10761110 0.81 ALDH1A1 (0.50) ALDH1A1TSHRMAOBAOC3SIGMAR1
SCHEMBL7324033 0.79 ALDH1A1 (0.54) ALDH1A1TSHRCARM1PRMT6PRMT8
Dibemethine SCHEMBL10542007 0.78 ALDH1A1 (0.70) ALDH1A1TSHRCARM1PRMT6PRMT8
Dibemethine SCHEMBL276863 0.78 ALDH1A1 (0.70) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL265489 0.78 ALDH1A1 (0.52) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL185582 0.78 PYCR1 (0.67) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL9687347 0.76 ALDH1A1 (0.50) ALDH1A1TSHRCARM1PRMT6PRMT8
Hydrochloric Acid SCHEMBL251246 0.76 PYCR1 (0.65) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL10177412 0.76 ALDH1A1 (0.50) ALDH1A1TSHRCARM1PRMT6PRMT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 US disclosed
US-20040259890-A1 Spiro compounds MSD K.K. (JP) 2004-12-23 US disclosed
CN-1538956-A Spiro compounds ������ҩ��ʽ���� 2004-10-20 CN disclosed
EP-1415986-A1 SPIRO COMPOUNDS BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259890-A1 Spiro compounds OPRD1, PER2, OPRK1 ALDH1A1 1250/4885TSHR 308/4885CARM1 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.